Company: BLCO
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001860742-25-000004
Chunk: 498

Company: Bausch & Lomb Corp
Filing Date: 2025-02-19
Form: 10-K
Item: Item 2
Chunk 498
---
, net3,494 3,589 Goodwill4,523 4,575 Deferred tax assets, net885 921 Other non-current assets (Note 3)294 225 Total assets$13,469 $13,442 Liabilities Current liabilities: Accounts payable (Note 3)$389 $522 Accrued and other current liabilities1,309 1,027 Current portion of long-term debt40 30 Total current liabilities1,738 1,579 Deferred tax liabilities, net13 14 Other non-current liabilities430 397 Long-term debt4,744 4,532 Total liabilities6,925 6,522 Commitments and contingencies (Notes 19 and 20)Equity  Common shares, no par value, unlimited shares authorized, 352,402,374 and 350,913,804 issued and outstanding at December 31, 2024 and December 31, 2023, respectively— — Additional paid-in capital8,429 8,349 Accumulated deficit(571)(254)Accumulated other comprehensive loss(1,385)(1,245)Total Bausch + Lomb Corporation shareholders’ equity6,473 6,850 Noncontrolling interest71 70 Total equity6,544 6,920 Total liabilities and equity$13,469 $13,442 On behalf of the Board:/s/ BRENTON L. SAUNDERS/s/ SARAH B. KAVANAGHBrenton L. Saunders Sarah B. KavanaghChairman of the Board and Chief Executive Officer Chairperson, Audit and Risk CommitteeThe accompanying notes are an integral part of these consolidated financial statements.

F-5

BAUSCH + LOMB CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS(in millions, except per share amounts) Years Ended December 31, 202420232022Revenues  Product sales$4,774 $4,131 $3,746 Other revenues17 15 22 4,791 4,146 3,768 ExpensesCost of goods sold (excluding amortization and impairments of intangible assets) (Note 3)1,868 1,640 1,511 Cost of other revenues4 2 8 Selling, general and administrative (Note 3)2,082